aiming to improve survival in cancer.
February 8, 2024: onthly Information Regarding the Total Number of Voting Rights and Shares Comprising the Share Capital
January 22, 2024: MaaT Pharma: Half-year Report on Liquidity Contract With the Brokerage Firm Kepler Cheuvreux
Like what you see?
Join the MaaT Pharma adventure!
Bring your talents, your passion and join an inclusive, creative, and multidisciplinary team. We aim to leverage the potential of microbiome to improve the treatment of patients with cancer.
Learn more about our values, our environment and see what we have to offer to you!